Conference abstractPublished 28 Sep 2015
Winter, spring, summer: A new generation of clinical trials for presonalized cancer medicine
Ben-Gurion Univeristy, Israel
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The move toward precision cancer medicine challenges traditional approaches both in terms of cancer medicine and in terms of clincal trial designs. The WIN consortium was established to promote translational cancer research by facilitating the translation of innovative methodologies to cancer care via collaborative and create clinical trials. The consortium has launched the Winter trial, in which mutations profiling and expression profiling are used to prioritize therapeutic approaches in advanced cancer patients. We are also launching two additional trials, Spring and Summer, which gradually attempt to benefit earlier stages of specific cancers. In this presentation the 3 trials will be briefly described, both in terms of the unique trial designs and in terms of the prioritization principles. I will then show the results we have recently obtained that show that exploring the immune system in situ in the tumor is feasible, and that immune monitoring is useful for predicting treatment efficacy. Altogether we will present exampels of modern, personalized clinical trials and propose that adding immune-monitoring to such trials could strengthen our ability to utilize immunological breakthroughs at the bedside.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectOncology & Cancer
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Eitan Rubin”